Free public records show Definium Therapeutics US, Inc. in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Definium Therapeutics US, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
5 active studies led by Definium Therapeutics US, Inc., of 8 in all
Source: ClinicalTrials.gov, Studies with Definium Therapeutics US, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies Definium Therapeutics US, Inc. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Definium Therapeutics US, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Definium Therapeutics US, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Definium Therapeutics US, Inc. is in.
Stories on the topics Definium Therapeutics US, Inc. works in.
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read
Depression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Read
About 322 million people live with depression. Treatment works, but most people still do not get it.
ReadSearch all reports for Definium Therapeutics US, Inc. All companies